Brefeldin A (BFA), a fungal metabolite that blocks transport of newly synthesized proteins from the endoplasmic reticulum, was found to inhibit poliovirus replication 105-to 106-fold. BFA does not inhibit entry of poliovirus into the cell or translation of viral RNA. Poliovirus RNA synthesis, however, is completely inhibited by BFA. A specific class of membranous vesicles, with which the poliovirus replication complex is physically associated, is known to proliferate in poliovirus-infected cells. BFA may inhibit poliovirus replication by preventing the formation of these vesicles.
Poliovirus is a nonenveloped, icosahedral RNA virus. Poliovirus genome replication, protein synthesis, and virion formation occur in the cytoplasm of infected primate cells. Poliovirus enters the cell via its receptor on the plasma membrane, a member of the immunoglobulin superfamily of proteins (29) . Following entry, the 7,500-nucleotide positivesense poliovirus genome directs the synthesis of a 220-kDa polyprotein. The polyprotein is subsequently processed into smaller polypeptides, including at least five polypeptides (2B, 2C, 3AB, 3CD, and 3D, the viral RNA-dependent RNA polymerase) involved in the replication of viral RNA (33) .
During poliovirus infection, drastic alterations in cellular morphology and metabolism occur. These changes, collectively known as the cytopathic effect, are the results of the inhibition of host cell protein synthesis (17, 39) , the reorganization of the cytoskeleton (24, 44) , and the proliferation of membranous vesicles (3, 4, 9, 15, 33) . The inhibition of host cell protein synthesis is mediated by viral protein 2A (2) . Even the small amount of 2A translated from the input genomic RNAs at high multiplicities of infection (MOIs) leads to the cleavage of the host cell's mRNA cap-binding protein p220 and the subsequent inactivation of the capbinding complex required for translation of almost all cellular mRNAs (39) . Poliovirus RNA is translated by a capindependent mechanism (31, 46) . Inhibition of host cell translation presumably facilitates poliovirus infection by freeing ribosomes from cellular mRNAs and thus increasing the rate of accumulation of poliovirus proteins (2, 39) .
The functions of other changes in the host cell during poliovirus infection are beginning to be better understood as well. For example, the poliovirus replication complex is associated with the membranous vesicles that proliferate during infection. The interaction between the replication complex and these vesicles is thought to be mediated by the viral 2C and 3AB polypeptides (3, 32) . Concomitant with the formation of these vesicles, there is an increase in phosphatidylcholine synthesis (9) . An inhibitor of lipid synthesis, cerulenin, inhibits poliovirus RNA synthesis, suggesting that the formation of these vesicles is at least in part a result of de novo lipid synthesis and that these vesicles are required for RNA replication (18) . The origin of the vesicles associated with the poliovirus replication complex and the mechanism of their formation are not known. Electron microscopic observations suggest that at least some of the poliovirus-* Corresponding author. induced vesicles are formed by budding from the endoplasmic reticulum (ER) (9, 15) .
The fungal metabolite brefeldin A (BFA) has been used to study membrane traffic in eukaryotic cells (16, 25, 26, 29, 30, 40) . BFA blocks protein transport from the ER to the Golgi apparatus (16, 25, 26, 29 ). There appears to be an ongoing, two-way traffic between the ER and the Golgi apparatus. BFA, by inhibiting the ER-to-Golgi path, leads to the redistribution of Golgi membranes and proteins into the ER (16, 25, 29) . BFA also inhibits the formation of non-clathrincoated vesicles from the Golgi apparatus in vitro (30) . BFA does not affect other cellular processes involving membranes such as endocytosis, endosome acidification, or lysosome function (29) . Since BFA is thought to inhibit the formation of specific classes of vesicles (30), we reasoned BFA might also block the proliferation of vesicles in poliovirus-infected cells. In fact, BFA is one of the most potent inhibitors of poliovirus replication yet described, specifically blocking poliovirus RNA replication.
MATERUILS AND METHODS
Cell culture and drug treatment. HeLa cells were grown in spinner culture in minimal essential medium (MEM) (Sigma) supplemented with 7% horse serum (GIBCO), 100 U of penicillin G per ml, and 100 ,ug of streptomycin sulfate per ml (MEM/complete). For growth on plates, cells were kept in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% calf serum (GIBCO), and penicillin G and streptomycin as described above (DMEM/complete). BFA (Epicentre Technologies) was stored as a 5-mg/ml solution in ethanol, nocodazole (Sigma) was stored as a 10-mg/ml solution in dimethyl sulfoxide, guanidine-HCl was stored as a 100 mM solution in phosphate-buffered saline (PBS), and actinomycin D (Sigma) was stored as a 5-p,g/ml solution in water. (37) .
To measure the amount of adenovirus DNA synthesis during infection, whole-cell extracts from 5 x 106 cells were prepared and phenol extracted, and the nucleic acids were collected by ethanol precipitation (37) . Dot blot analysis was performed using a Lucite manifold (Schleicher and Schuell) and a 32P-labeled adenovirus DNA probe as described previously (37 (Fig. lb) ; however, those cells that were stained by the antibody were stained as strongly as control, i.e., poliovirus-infected cells ( Fig. la and b ). This experiment provided the first evidence that BFA inhibits poliovirus infection. We chose to use a BFA concentration of 2 ,ug/ml for subsequent experiments, since it produced a complete inhibition of virion production as assayed by immunofluorescence microscopy and eliminated the variability of inhibition seen at 1 ,ug of BFA per ml. This concentration of BFA is comparable to those used by others to document the specific effects of BFA on protein secretion; these concentrations have ranged from 1 pg/ml (29) to 10 ,ug/ml (26) .
To characterize the effect of BFA on poliovirus infection further, cells were infected with poliovirus at an MOI of 0. 25 and incubated in the presence or absence of 2 ,ug of BFA per ml. The yield of infectious poliovirus from equal numbers of cells was determined from 0 to 8 h postinfection. Figure 2a shows the observed reduction in poliovirus titer, a decrease of 5 to 6 orders of magnitude in the presence of BFA. A BFA-sensitive step occurs after the entry of poliovirus' into cells. To determine the step(s) in the infectious cycle at which BFA affects poliovirus growth, we examined the effects of BFA on cell entry, protein synthesis, and RNA synthesis individually. The first step in poliovirus infection is virion binding to the poliovirus receptor (28) and release of the viral mRNA into the cell. To bypass the cell entry and RNA release steps, poliovirus infection was initiated by electroporation of poliovirus RNA into HeLa cells, and the transfected cells were grown in the presence or absence of BFA. Duplicate transfections in the absence of BFA (Fig.  2b) showed viral yields greater than 106 PFU/ml in the resulting cytoplasmic extracts. As with virion-infected cells, BFA completely inhibited virus production in RNA-transfected cells. The virus yields in duplicate transfections incubated in the presence of BFA were lower than 5 PFU/ml at every time point examined, a reduction in titer of 6 orders of magnitude (Fig. 2b) .
That this inhibition was seen even when the infection was initiated by RNA transfection is evidence that BFA affects a step in the poliovirus infectious cycle which follows the binding of the virion to its receptor and the subsequent release of the viral RNA into the cytoplasm.
BFA does not inhibit poliovirus translation. The next step leading to a productive poliovirus infection is the translation of the poliovirus genome. A sensitive assay for translation of poliovirus proteins early in infection is to monitor the inhibition of host protein synthesis. Translation of only the input RNA molecules can be followed by performing an infection at a high MOI in the presence of guanidine hydrochloride, an inhibitor of poliovirus RNA synthesis (8) . Figure 3a shows the labeled proteins synthesized following infection by poliovirus in the presence (lanes 11 to 14) and absence (lanes 1 to 4) of 1 mM guanidine. Cells were labeled with [35S]methionine for 20 min prior to harvest, and equal numbers of cells were harvested at 2, 3, 4 and 5 h postinfection. During poliovirus infection in the absence of the RNA replication inhibitor, both the accumulation of labeled poliovirus proteins and the inhibition of host cell protein synthesis (17, 39) were seen (Fig. 3a, lanes 1 to 4) . For The translation products that accumulated in the presence of 2 ,ug of BFA per ml are shown in lanes 6 to 9 of Fig. 3a . The time course of [35S]methionine incorporation was nearly identical to that observed in guanidine-treated cells, showing that the input poliovirus RNA could be translated in the presence of BFA. Thus, translation of the poliovirus proteins early in the infectious cycle is not affected by the presence of BFA.
To determine whether translation of poliovirion RNA later in infection was affected by BFA, the inhibitor was added to the medium of HeLa cells 3 h postinfection with poliovirus.
FNure 3b shows the accumulation of proteins labeled with [3 S]methionine during a 20-min labeling interval. This interval followed 10 min after the addition of no inhibitor (lane 2), BFA (lane 3), or guanidine (lane 4); 10 min is sufficient time for BFA to take effect (16, 26) . It is apparent that viral translation late in infection, as well as early, is unaffected by the addition of BFA.
One significant difference between the 35S-labeled proteins that accumulated in guanidine-treated cells and those in BFA-treated cells was an increased amount of an approximately 80-kDa protein in the infected cells treated with BFA (Fig. 3a) . This 80-kDa protein comigrated with a labeled species derived from mock-infected, BFA-treated cells in one-dimensional gels (data not shown) and thus is likely to be a host protein. Sarnow (36) (27) in poliovirus-infected cells even after the translation of most cellular proteins has been inhibited.
To determine whether the BFA-induced 80-kDa protein was a glucose-regulated protein such as grp78/BiP, twodimensional gel electrophoresis was performed on [35S]methionine-labeled extracts of cells deprived of glucose (Fig.  4) . In the absence of glucose, the relative amount of an approximately 80-kDa protein was greatly increased (Fig. 4a  and b ). This 80-kDa protein comigrates with a polypeptide which is present in both poliovirus-infected and uninfected cells in the presence (Fig. 4d) of BFA. On the basis of its comigration with the 80-kDa protein whose synthesis is enhanced during glucose deprivation and the known ability of grp78IBiP mRNA to be translated during poliovirus infection (27, 36) Addition of BFA to poliovirus-infected cells 3 h postinfection also inhibited new poliovirus RNA synthesis (Fig. Sa) , indicating that BFA could inhibit poliovirus RNA synthesis even after substantial amounts of poliovirus proteins were present. When unlabeled uridine in a 5,000-fold molar excess to [3H] uridine was added at 3 h postinfection along with BFA, the amount of trichloroacetic acid-insoluble radioactivity did not diminish substantially. Therefore, BFA does not act by destabilizing previously synthesized poliovirus RNA. Furthermore, 2 jig of BFA per ml had little effect on host cell RNA synthesis over a 7-h period (Fig. Sb) .
The inhibition of poliovirus infection by BFA is reversible. The inhibitory effects of BFA on ER-to-Golgi protein transport have been shown to be reversible; normal function is resumed within minutes of the removal of BFA from the culture medium (26) . To examine the reversibility of BFA's effect on poliovirus replication, poliovirus-infected cells were incubated with BFA for 1, 2, or 3 h before the medium was replaced with drug-free medium. Figure 6a shows the effect of these treatments on virus yield throughout a singlecycle infection.
As was documented in Fig. 2a , the presence of BFA throughout the course of the poliovirus infectious cycle resulted in a greater than 105-fold inhibition of poliovirus growth. When BFA was removed from the culture medium 1 h after infection, the growth curve of poliovirus did not differ significantly from that of the poliovirus infection in the complete absence of BFA. However when BFA was removed from the culture medium at 3 h postinfection, a 2-h delay in virus production was observed. An intermediate effect was observed when BFA was removed at 2 h postinfection. Despite the delays, by 8 h postinfection, the yields of poliovirus in samples treated with BFA early in infection were similar to that found in the untreated infection (Fig. 6a) . Thus, the recovery of the poliovirus infections after BFA treatment was complete; the lag in virus production when BFA was present early in infection presumably reflects the necessity to establish physical structures within the cell necessary for viral RNA synthesis, the time needed to package newly synthesized RNAs into infectious virions, or both.
The data in Figure 6a show that although the inhibition of poliovirus growth was reversible, virus growth was very sensitive to BFA from 1 to 3 h postinfection. Figure 6b shows that when BFA was not added until 3 h postinfection, substantial amounts of virions were still produced. unlikely that later events in virus growth, like RNA packaging and virus assembly, were affected by BFA. When BFA was added 1.5 h postinfection, however, very little virus was produced. Taken together, the data in Fig. 6a and b argue that the most BFA-sensitive period in the poliovirus infectious cycle is from -1 to 3 h postinfection.
BFA does not inhibit lipid synthesis in poliovirus-infected cells. Since the inhibition of lipid synthesis by cerulenin (18) has been reported to inhibit poliovirus replication 100-fold, one explanation of the inhibition of poliovirus RNA synthesis by BFA might be a similar inhibition of lipid synthesis. (Fig. 7a) into uninfected HeLa cells was not significantly affected by the presence of 2 ,ug of BFA per ml although the rate of incorporation of ["4C]glycerol (Fig. 7b) was inhibited slightly. This observation suggests that BFA produces a slight inhibition in the synthesis of a class of nonphospholipid glycerol lipids. However, it is clear from these data that the inhibition of poliovirus replication by BFA is not mediated by global inhibition of lipid synthesis.
In poliovirus-infected cells, there was a small, but significant, increase in the rate of incorporation of both ['4CJglyc-erol and to a lesser extent of [3H]choline into lipid compared with uninfected cells (9; Fig. 7 ), suggesting that in addition to phospholipids, the synthesis of a particular, nonphospholipid class of glycerol lipids was preferentially stimulated in poliovirus-infected cells. Of greater importance here, however, was the observation that BFA inhibited the poliovirusinduced stimulation of lipid synthesis, i.e., the rate of phospholipid synthesis in BFA-treated, poliovirus-infected cells returned to that of uninfected cells (Fig. 7a) .
BFA does not inhibit adenovirus replication. BFA is sometimes described as an antiviral compound on the basis of its inhibition of replication of herpes simplex virus and Newcastle disease virus (42), both enveloped viruses, and its inhibition of the glycosylation of vesicular stomatitis virus G protein (16, 40) . Recently, specific effects of BFA on the infectious cycles of several other enveloped viruses have been reported (12, 13, 45) . The known effects of BFA on protein secretion are sufficient to explain the inhibition by BFA of any virus that requires newly synthesized glycosylated, secreted, or membrane-bound proteins during its infectious cycle. The inhibition of poliovirus infection by BFA cannot be explained in this simple manner, since poliovirus encodes no glycosylated or secreted proteins. However, we wanted to demonstrate that another virus whose metabolic requirements did not necessarily involve the protein secretion apparatus for infectivity was not inhibited by BFA. period. We conclude that BFA does not inhibit adenovirus infection in HeLa cells.
DISCUSSION
Three to four hours after infection with poliovirus, human cells fill with small membranous vesicles (10, 11, 15) . These vesicles are associated with the poliovirus replication complex (3) (4) (5) . Their formation is thought to require the synthesis of poliovirus proteins (6, 19) and their appearance coincides with the commencement of poliovirus RNA synthesis (4) . Three lines of evidence argue that these vesicles are important in poliovirus RNA synthesis. First, newly synthesized poliovirus RNA molecules and several viral proteins known to be involved in viral RNA synthesis are physically associated with these vesicles (3) (4) (5) . Second, preparations of membranes from infected cells, termed crude replication complexes, are capable of synthesizing poliovirus RNA in vitro (32, 41, 43) . Third, cerulenin, an inhibitor of lipid synthesis, blocks poliovirus RNA synthesis and lowers the yield of virus 100-fold (18) . While these data offer evidence that cellular membranes, and probably the small vesicles that appear in poliovirus-infected cells, are important for poliovirus RNA synthesis, they yield little insight into the derivation of these vesicles or the mechanism by which poliovirus infection induces their accumulation.
Small membranous vesicles are responsible for the movement of newly synthesized proteins from the ER to the Golgi apparatus and between compartments of the Golgi stack (34, 35) . BFA was discovered over 30 years ago (38) and recently has been widely used to study membrane traffic and protein processing in eukaryotic cells (16, 25, 26, 29, 30, 40) . After treatment of mammalian cells with BFA, ER to Golgi transport is rapidly inhibited. Because retrograde transport from the Golgi to the ER continues, the Golgi apparatus resorbs into the ER, resulting in a mixing of the two compartments in the presence of BFA (26, 29, 30) . Retrograde transport is microtubule dependent, and the mixing of the ER and Golgi compartments in the presence of BFA can be inhibited by simultaneous treatment with nocodozole (25, 30) .
The inhibition of poliovirus replication by BFA occurs at low concentrations and is not due to the inhibition of viral entry into the cell, the release of the poliovirus RNA ( Fig. 2  and 3a) , or the translation of viral RNA either early or late in the infectious cycle (Fig. 3 ). BFA's effect also does not appear to be related to nonspecific effects on host cell transcription (Fig. 5b) or phospholipid synthesis, although a modest reduction of all glycerol lipid synthesis was observed (Fig. 7) . BFA did not inhibit viral translation either early (Fig. 3a) or later (Fig. 3b) in the infectious cycle. Surprisingly, a cellular protein present in the lumen of the ER, grp78/BiP, not only continued to be translated in poliovirusinfected cells (36) , but its synthesis was apparently stimulated in the presence of BFA (Fig. 4) . BFA had no effect on the viral yield or viral DNA synthesis rate of another nonenveloped virus, adenovirus (Fig. 8) , which has a completely different replication strategy from that of poliovirus (20) . (14) ; both events occur independently of cellular membrane systems (14, 33) . Therefore, poliovirus infection should not display a strict requirement for the protein glycosylation and secretion functions of the ER and Golgi apparatus. We suggest that BFA may inhibit poliovirus growth by inhibiting the formation of a specific class of vesicles required in infected cells for polioviral RNA synthesis (Fig. 9 ). As discussed above, J. VIROL. the effects of BFA on protein traffic are most consistent with inhibition of the formation of vesicles involved in ER-toGolgi and intra-Golgi traffic (25, 26, 29, 30) .
The greater stimulation of total glycerol lipids than of phospholipid (Fig. 7) during poliovirus infection and the inhibition of this stimulation by BFA, together with the inhibitory effects of the lipid synthesis inhibitor cerulenin (18) on poliovirus replication, suggest that a particular class of glycerol lipid may be utilized in the synthesis of the poliovirus-induced vesicles. The inhibition of poliovirus infection by BFA even in the presence of nocodozole argues that fragmentation of the Golgi apparatus and its resorption into the ER in the presence of BFA are not responsible for the inhibition of viral RNA synthesis.
In addition to the known specificity of BFA, several findings presented here are consistent with the idea that the BFA-sensitive step in poliovirus RNA synthesis is the formation of the virus-induced vesicles. First, the time (1 to 3 h postinfection) at which the inhibition of poliovirus growth by BFA is most pronounced (Fig. 6) is the time at which the poliovirus-induced vesicles first form (4) . Second, after the removal of BFA from poliovirus-infected cells, it takes approximately 2 h before the production of virions begins (Fig. 6 ). This surprisingly long lag time may include the time needed to synthesize vesicular structures necessary for viral RNA synthesis.
The major prediction of the model shown in Fig. 9 is that poliovirus encodes an activity or takes advantage of an activity inherent to cells that blocks membrane fusion and thereby leads to the accumulation of vesicles derived from the cell's membranous compartments. Our model predicts that BFA inhibits poliovirus RNA synthesis by blocking the formation of these vesicles (Fig. 9c) . This model also suggests that poliovirus, not needing the glycosylation or secretion functions of the host cell, usurps the host's membrane system for its own highly specialized needs. Of course, it is also possible that BFA directly inhibits a particular host protein or proteins required for poliovirus replication. Work is in progress to distinguish between these models for BFA's effect on poliovirus replication.
